drugset / Trial / NCT05523297

Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery

NCT05523297 ↗

Phase 3 Completed 420 enrolled Octapharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a multicenter, active-control randomized, prospective, Phase 3 study in adult cardiac surgery patients. 420 patients were randomized at 12 hospitals.

Timeline

Start
2022-11-30
Primary completion
2024-06-27
Completion
2024-06-27

Outcome

Met primary endpoint

paper had higher hemostatic effectiveness (166 [77.9%] vs 125 [60.4%]; difference, 17.6%; 95% CI, 8.7%-26.4%; P < .001 for noninferiority and superiority) PMID 40156829 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Frozen Plasma Product, Human Protein / enzyme biologic 3 unknown —
Comparator Frozen Plasma Product, Human Protein / enzyme biologic 4 unknown —
Subject Octaplex Protein / enzyme biologic 1500 iu —
Subject Octaplex Protein / enzyme biologic 2000 iu —

Indications

No indication recorded.